Company / Current Liabilities per Share
Biogen Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$23.12
FY2025
5-year range
$21.48 / $38.39
FY2021-FY2025
Trend
-39.8%
vs FY2024
Sector context
#8 of 212
Health Care
What the data says
Among 212 Health Care companies, Biogen is in the bottom 4% for current liabilities per share. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $15.26 in FY2018 to $38.39 in FY2024.
Based on SEC 10-K filings.
23.12 in FY2025 with a 5-year CAGR of +4.0%. Top quartile in the Health Care sector.
Remained stable around $23.12 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
+47.8% above sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 39.8% year-over-year.
- Ranks #8 out of 212 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.12 | -39.8% |
| FY2024 | $38.39 | +64.3% |
| FY2023 | $23.36 | +8.8% |
| FY2022 | $21.48 | -13.0% |
| FY2021 | $24.67 | +30.0% |
| FY2020 | $18.98 | -17.5% |
| FY2019 | $23.00 | +50.7% |
| FY2018 | $15.26 | -2.2% |
| FY2017 | $15.60 | -0.3% |
| FY2016 | $15.64 | +42.4% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026